Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Renal cell carcinoma | R-HSA-9794523 | map05211 | cinchonidine | 101744 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | cinchonidine | 101744 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | cinchonidine | 101744 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cinchonidine | 101744 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | cinchonidine | 101744 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | cinchonidine | 101744 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | acepromazine | 6077 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | acepromazine | 6077 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | acepromazine | 6077 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | acepromazine | 6077 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | acepromazine | 6077 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | acepromazine | 6077 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | acepromazine | 6077 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | acepromazine | 6077 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | berberine | 5283066 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | berberine | 5283066 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | berberine | 5283066 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | berberine | 5283066 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | berberine | 5283066 | drug-path |
| Glioma | Q9NZM4 | map05214 | hydroquinine | 121515 | drug-path |